CodeLab Capital AS CODE
Oslo Børs · Healthcare · Health Information Services
4.74 NOK
−1.9%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for CodeLab Capital
| NOK million | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | – | 195 | 59 | 0 | 11 |
| EBITDA | – | −20 | 91 | −71 | −12 |
| Net income | – | −155 | 30 | −151 | −15 |
| Balance sheet | |||||
| Equity | – | 599 | 134 | 18 | 29 |
| Total debt | 214 | 217 | 0 | – | 3 |
| Cash | – | 56 | 56 | 20 | 14 |
| Net debt | – | 162 | −56 | – | −11 |
| Ratios and per share | |||||
| EBITDA margin | – | −10.4% | 154.2% | −28,545.6% | −113.5% |
| Profit margin | – | −79.3% | 50.8% | −60,501.9% | −139.6% |
| Return on equity | – | −25.8% | 22.5% | −842.6% | −51.9% |
| Earnings/share (NOK) | – | −38.87 | 7.55 | −22.07 | −1.03 |
| Book value/share (NOK) | – | 150.71 | 33.58 | 2.62 | 1.98 |
| Shares outstanding (M) | – | 4 | 4 | 7 | 14 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | – |
| P/B | 2.4 |
| EV / EBITDA | – |
| Net debt / EBITDA | – |
| Return on equity | −51.9% |
| Profit margin | −139.6% |
| Beta 1Y | 0.86 |
| Revenue growth 1Y | +4,173.0% |
| Revenue CAGR 3Y | −62.1% |
| ROE avg. 3Y | −290.7% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (NOK)
| 2023 | 125.00 |
Not investment advice. Figures may contain errors from the data source.